Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease
Clinical trial NCT03870334 · TERMINATED
Trial details
- NCT number
- NCT03870334
- Sponsor
- NImmune Biopharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2022-08-26
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.